About Pneumonia Testing Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection. Mostly, it affects people with weakened immune systems and is common in children and older people. Technavio’s analysts forecast the global pneumonia testing market to grow at a CAGR of 9.91% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global pneumonia testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various diagnostic tests for pneumonia (community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP)) to key end-users such as hospitals, diagnostic laboratories, and homecare. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Pneumonia Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of... Research Beam Model: Research Beam Product ID: 1237648 3500 USD New
Global Pneumonia Testing Market 2017-2021
 
 

Global Pneumonia Testing Market 2017-2021

  • Category : Healthcare
  • Published On : February   2017
  • Pages : 117
  • Publisher : Technavio
 
 
 
About Pneumonia Testing

Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection. Mostly, it affects people with weakened immune systems and is common in children and older people.

Technavio’s analysts forecast the global pneumonia testing market to grow at a CAGR of 9.91% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global pneumonia testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various diagnostic tests for pneumonia (community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP)) to key end-users such as hospitals, diagnostic laboratories, and homecare.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Pneumonia Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abbott Molecular
• bioMérieux
• Becton, Dickenson and Company (BD)
• Roche Molecular Diagnostics
• Thermo Fisher Scientific

Other prominent vendors
• AdvanDx
• Alere
• Beckman Coulter
• Bio-Rad
• Cepheid
• Concile
• Diamedix
• DiaSorin
• Eiken Chemical
• Fast-track diagnostics
• Hologic
• Meridian Biosciences
• Qiagen
• Quest Diagnostics
• Quidel
• SeraCare
• Trinity Biotech

Market driver
• Increased awareness regarding early diagnosis and preventive measures.
• For a full, detailed list, view our report

Market challenge
• Limited detection capability and accuracy.
• For a full, detailed list, view our report

Market trend
• Growing consumer shift toward direct-to-consumer testing.
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Pneumonia: An overview
• Market snapshot
PART 05: Market landscape
• Market overview
• Market size and forecast
• Buying criteria
• Five forces analysis
PART 06: Market segmentation by product type
• Global pneumonia testing market by analyzers
• Global pneumonia testing market by consumables
PART 07: Market segmentation by method
• Immunodiagnostics
• Molecular diagnostics
• POC
• Global pneumonia testing market by immunodiagnostics
• Global pneumonia testing market by molecular diagnostics
• Global pneumonia testing market by POC
PART 08: Market segmentation by technology
• ELISA
• Immunofluorescence
• Western blot
• PCR
• IHC
• NASBA
• Others
PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic laboratories
• Homecare
• Others
PART 10: Geographical segmentation
• Pneumonia testing market in the Americas
• Pneumonia testing market in EMEA
• Pneumonia testing market in APAC
PART 11: Market drivers
• Increased awareness regarding early diagnosis and preventive measures
• Growing popularity of POC testing
• Marketing strategies of vendors
• Improvement in healthcare infrastructure
PART 12: Impact of drivers
PART 13: Market challenges
• Limited detection capability and accuracy
• Presence of an undiagnosed population
• Regulatory and economic hurdles
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Increase in adoption of molecular diagnostic testing
• Growing consumer shift toward direct-to-consumer testing
• Shift from monoplex to multiplex testing
PART 16: Vendor landscape
• Competitive scenario
• Market share analysis
• Geographical presence of the key vendors
• Key news
PART 17: Key vendor analysis
• Abbott Molecular
• bioMérieux
• BD0
• Roche Molecular Diagnostics
• Thermo Fisher Scientific
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global pneumonia testing market by type 2016
Exhibit 03: Global pneumonia testing market: Analysis
Exhibit 04: Yearly prevalence of pneumonia, region wise
Exhibit 05: Market overview: Global pneumonia testing market
Exhibit 06: Global pneumonia testing market 2016-2021 ($ millions)
Exhibit 07: Global pneumonia testing market analysis: Developed and emerging markets
Exhibit 08: Key buying criteria in global pneumonia testing market
Exhibit 09: Buying criteria for pneumonia testing
Exhibit 10: Five forces analysis
Exhibit 11: Global pneumonia testing market segmentation by product type 2016
Exhibit 12: Global pneumonia testing market segmentation by product type 2021
Exhibit 13: Market overview: Global pneumonia testing market by analyzers
Exhibit 14: Global pneumonia testing market by analyzers 2016-2021 ($ millions)
Exhibit 15: Market overview: Global pneumonia testing market by consumables
Exhibit 16: Global pneumonia testing market by consumables 2016-2021 ($ millions)
Exhibit 17: Segmentation of pneumonia testing market by product type 2016-2021 ($ millions)
Exhibit 18: Segmentation of global pneumonia testing market by product type 2016-2021 (%)
Exhibit 19: Global pneumonia testing market by method
Exhibit 20: Global pneumonia testing market segmentation by method 2016
Exhibit 21: Global pneumonia testing market segmentation by method 2021
Exhibit 22: Global pneumonia testing market by immunodiagnostics 2016-2021 ($ millions)
Exhibit 23: Global pneumonia testing market by molecular diagnostics 2016-2021 ($ millions)
Exhibit 24: Global pneumonia testing market by POC 2016-2021 ($ millions)
Exhibit 25: Segmentation of pneumonia testing market by method 2016-2021 ($ millions)
Exhibit 26: Segmentation of pneumonia testing market by product type 2016-2021 (%)
Exhibit 27: Global pneumonia testing market by technology
Exhibit 28: Global pneumonia testing market by technology 2016
Exhibit 29: Global pneumonia testing market segmentation by end-users 2016
Exhibit 30: Global pneumonia testing market segmentation by geography 2016
Exhibit 31: Global pneumonia testing market segmentation by geography 2021
Exhibit 32: Global pneumonia testing market: Country-wise revenue and growth analysis 2016
Exhibit 33: Global pneumonia testing market: Geography lifecycle analysis 2016
Exhibit 34: Market overview: Americas
Exhibit 35: Pneumonia testing market in Americas 2016-2021 ($ millions)
Exhibit 36: Country-wise analysis: Americas
Exhibit 37: Market overview: EMEA
Exhibit 38: Pneumonia testing market in EMEA 2016-2021 ($ millions)
Exhibit 39: Country-wise analysis: EMEA
Exhibit 40: Market overview: APAC
Exhibit 41: Pneumonia testing market in APAC 2016-2021 ($ millions)
Exhibit 42: Country-wise analysis: APAC
Exhibit 43: Global pneumonia testing market segmentation by geography 2016-2021 (%)
Exhibit 44: Global pneumonia testing market segmentation by geography 2016-2021 ($ millions)
Exhibit 45: Geographical overview: Global pneumonia testing market
Exhibit 46: Yearly country-wise death rates per 100,000 population due to pneumonia on average 2015
Exhibit 47: Marketing strategies of global vendors
Exhibit 48: Impact of drivers
Exhibit 49: Recent initiatives taken to combat antibiotic resistance
Exhibit 50: Country-wise regulatory requirements
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Acquisitions by global vendors in 2016
Exhibit 53: Competitive structure analysis of global pneumonia testing market 2016
Exhibit 54: Market penetration of pneumonia testing manufacturers globally (2016)
Exhibit 55: Strategic success factors of companies in global pneumonia testing market 2016
Exhibit 56: Share of vendors in global pneumonia testing market 2016
Exhibit 57: Regional analysis of key vendors 2016
Exhibit 58: Key highlights of Abbott Molecular
Exhibit 59: Abbott Molecular: Strength assessment
Exhibit 60: Abbott Molecular: Strategy assessment
Exhibit 61: Abbott Molecular: Opportunity assessment
Exhibit 62: Key highlights of bioMérieux
Exhibit 63: bioMérieux: Strength assessment
Exhibit 64: bioMérieux: Strategy assessment
Exhibit 65: bioMérieux: Opportunity assessment
Exhibit 66: Key highlights of BD
Exhibit 67: BD: Strength assessment
Exhibit 68: BD: Strategy assessment
Exhibit 69: BD: Opportunity assessment
Exhibit 70: Key highlights of Roche Molecular Diagnostics
Exhibit 71: Roche Molecular Diagnostics: Strength assessment
Exhibit 72: Roche Molecular Diagnostics: Strategy assessment
Exhibit 73: Roche Molecular Diagnostics: Opportunity assessment
Exhibit 74: Key highlights of Thermo Fisher Scientific
Exhibit 75: Thermo Fisher Scientific: Strength assessment
Exhibit 76: Thermo Fisher Scientific: Strategy assessment
Exhibit 77: Thermo Fisher Scientific: Opportunity assessment

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT